Digital therapeutics (DTx) has been in the spotlight a lot this year. Is Europe catching up (or pioneering the way) in DTx? Skye Hodson, Asset Strategy Director at Syneos Health provides insight into the latest advances in the emerging DTx sector in this PharmaTimes article.